Tech Company Financing Transactions
BioReact Funding Round
BioReact secured a funding round on 2/12/2026. Investors included Hurricane Ventures.
Transaction Overview
Company Name
Announced On
2/12/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Hurricane Ventures (Connor Sitton)
Proceeds Purpose
The funding will be used to accelerate go-to-market efforts and expand BioReact's product capabilities.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
1210 Waterway Boulevard 2000
Indianapolis, IN 46202
USA
Indianapolis, IN 46202
USA
Phone
Undisclosed
Website
Email Address
Overview
BioReact is an AI-powered software platform built for scientists growing cells in bioreactors across industrial biotech, biopharma, and synthetic biology. BioReact was founded in early 2023 to solve a growing challenge in the bioprocess industry: disjointed, siloed data that makes it difficult to apply AI and machine learning in the lab. While scientists were engineering cells to create life-saving and sustainable products, they lacked the digital tools to harness their data effectively.
Management Team
Browse more venture capital transactions:
Prev: 2/12/2026: Yosemite venture capital transaction
Next: 2/12/2026: Electric Twin venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








